Paraffin bath versus extracorporeal shock wave therapy: effects on median nerve thickness in carpal tunnel syndrome
Official title: Investigation of the Effects of Two Different Physiotherapy Modalities on Median Nerve Thickness, Electrophysiological Activity, Pain Intensity and Quality of Life in Patients With Carpal Tunnel Syndrome - An Observational Study
Run by Karadeniz Technical University · NCT07167667 · Data updated 2026-11-12
This will test if paraffin baths or extracorporeal shock wave therapy better reduce median nerve swelling and relieve numbness and pain in adults aged 30–60 with carpal tunnel syndrome.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 60 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Karadeniz Technical University Academic / other |
| Locations | 1 site (Istanbul) |
| Status | Recruiting |
| Started | October 25, 2024 |
| Main results expected | October 25, 2025 |
| Study ends | October 25, 2025 |
| Registry record updated | September 11, 2025 |
| Trial ID | NCT07167667 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 30–60 years old with clinician-diagnosed mild-to-moderate (stage 1–3) carpal tunnel syndrome, symptoms in the first three and part of the fourth finger, and positive Phalen/Tinel or Durkan tests who are appropriate for either a 10-session paraffin course or a 5-session ESWT course are ideal candidates.
✕Probably not a fit
Patients with thenar muscle atrophy, severe sensory/motor loss of the median nerve, prior hand/wrist surgery or injury, cervical radiculopathy/stenosis, or recent corticosteroid injection are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study will enroll 60 adults with clinician-diagnosed carpal tunnel syndrome and randomly assign them to one of two physiotherapy approaches. One group receives 10 paraffin bath sessions and the other group receives 5 sessions of extracorporeal shock wave therapy (ESWT). Outcomes are measured before and after treatment using ultrasound measurement of median nerve thickness, electromyography, a visual analog pain scale, and the SF-36 quality-of-life questionnaire. A specialist physician performs the pre- and post-treatment evaluations at a single center in Istanbul.
Why it matters
Potential benefit: If successful, the results could show which non-surgical treatment more effectively reduces nerve swelling and symptoms, helping clinicians choose better conservative care for CTS.
How similar studies have gone: Previous research has shown that ESWT can reduce symptoms for some patients with CTS while heat therapies like paraffin have more mixed evidence, and using ultrasound to measure median nerve thickness is an established outcome measure.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals between the ages of 30-60 who have been diagnosed with CTS by a specialist physician according to international criteria (Those between Stages 1-3), * Those who have complaints of numbness, tingling, and pain in the first three fingers and half of the fourth finger, * Phalen Test and Tinel sign or Durkan Test being positive * Patients who will receive 5 sessions of ESWT application prescribed by a Physical Medicine and Rehabilitation Specialist Physician (for the ESWT group) * Patients who have been recommended 10 sessions of Paraffin application by a Physical Medicine and Rehabilitation Specialist Physician (for the Paraffin group) Exclusion Criteria: * Presence of atrophy in the thenar muscles, * Insufficient sensory and motor response in the median nerve, * History of hand and/or wrist injury or surgery, * Those with cervical stenosis, cervical spondylosis, or cervical radiculopathy, * Corticosteroids in the carpal tunnel area within the last six months those who have had an injection, * Pregnancy or diabetes, renal failure, rheumatoid arthritis or hypothyroidism
Where it's running
-
Baltalimani Metin Sabanci Bone Diseases Training and Research Hospita
Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Esra Sonbahar Bolat, Physician
- Email: esra.sonbahar@hotmail.com
- Phone: +9005052686709
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound-Guided Injection for Carpal Tunnel Syndrome: Hyaluronic Acid vs Corticosteroid vs 5% Glucose
This study tests three ultrasound-guided injections (hyaluronic acid, corticosteroid, and 5% glucose) to see which best helps adults with mild to moderate carpal tunnel syndrome.
-
Open vs ultrasound-guided carpal tunnel release ( CTS )
This study compares two surgical approaches for carpal tunnel syndrome to see which helps people recover better after surgery.
-
Amniotic Membrane and Secretome Added to Carpal Tunnel Release
This trial tests whether adding amniotic membrane and secretome to carpal tunnel surgery helps people with moderate-to-severe CTS recover better than surgery alone.
-
Reliability and validity of hand function tests in carpal tunnel syndrome
This study tests whether three hand function tests (JTHFT, MDT, and Nine-Hole Peg Test) are reliable and valid for people with carpal tunnel syndrome.
-
Neuromobilization, Tendon Gliding, or Both for Mild to Moderate Carpal Tunnel Syndrome
This trial tests whether neuromobilization, tendon gliding exercises, or a combination of both help reduce pain and improve hand function in people with mild to moderate carpal tunnel syndrome.
-
MeDe: Carpal tunnel release with added lacertus release vs carpal tunnel release alone
In adults with carpal tunnel syndrome, this trial tests whether adding a lacertus fibrosus release to the standard carpal tunnel release helps reduce symptoms and improve hand function.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.